These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 26092643)

  • 1. Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities.
    Gish RG; Given BD; Lai CL; Locarnini SA; Lau JY; Lewis DL; Schluep T
    Antiviral Res; 2015 Sep; 121():47-58. PubMed ID: 26092643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the "magic bullet" to kill cccDNA.
    Zhang E; Kosinska A; Lu M; Yan H; Roggendorf M
    Antiviral Res; 2015 Nov; 123():193-203. PubMed ID: 26476376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological basis for functional cure of chronic hepatitis B.
    Martinez MG; Testoni B; Zoulim F
    J Viral Hepat; 2019 Jul; 26(7):786-794. PubMed ID: 30803126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis B: what should be the goal for new therapies?
    Block TM; Gish R; Guo H; Mehta A; Cuconati A; Thomas London W; Guo JT
    Antiviral Res; 2013 Apr; 98(1):27-34. PubMed ID: 23391846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.
    Guo JT; Guo H
    Antiviral Res; 2015 Oct; 122():91-100. PubMed ID: 26272257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus-host interactions and novel targets for viral cure.
    Ligat G; Verrier ER; Nassal M; Baumert TF
    Curr Opin Virol; 2021 Aug; 49():41-51. PubMed ID: 34029994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent.
    Gish RG; Yuen MF; Chan HL; Given BD; Lai CL; Locarnini SA; Lau JY; Wooddell CI; Schluep T; Lewis DL
    Antiviral Res; 2015 Sep; 121():97-108. PubMed ID: 26129970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of pre-core mutant chronic hepatitis B.
    Papatheodoridis GV; Hadziyannis SJ
    J Viral Hepat; 2001 Sep; 8(5):311-21. PubMed ID: 11555188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological Basis for the Cure of Chronic Hepatitis B.
    Hu J; Cheng J; Tang L; Hu Z; Luo Y; Li Y; Zhou T; Chang J; Guo JT
    ACS Infect Dis; 2019 May; 5(5):659-674. PubMed ID: 29893548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis B: A wave of new therapies on the horizon.
    Block TM; Rawat S; Brosgart CL
    Antiviral Res; 2015 Sep; 121():69-81. PubMed ID: 26112647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future directions for the management of hepatitis B.
    Dusheiko G
    S Afr Med J; 2018 Aug; 108(8b):22-30. PubMed ID: 30182909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natural history of chronic hepatitis B virus infection].
    Vildózola Gonzales H; Salinas JL
    Rev Gastroenterol Peru; 2009; 29(2):147-57. PubMed ID: 19609330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus.
    Durantel D; Zoulim F
    J Hepatol; 2016 Apr; 64(1 Suppl):S117-S131. PubMed ID: 27084032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting Hepatitis B Virus: Challenges of Curative Therapies.
    Hu J; Protzer U; Siddiqui A
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
    Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
    J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: novel therapies for hepatitis B virus cure - advances and perspectives.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2016 Aug; 44(3):213-22. PubMed ID: 27302653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune balance in Hepatitis B Infection: Present and Future Therapies.
    Vyas AK; Jindal A; Hissar S; Ramakrishna G; Trehanpati N
    Scand J Immunol; 2017 Jul; 86(1):4-14. PubMed ID: 28387980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.